SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome

Erstveröffentlichung
2022Authors
Hasselblatt, Martin
Thomas, Christian
Federico, Aniello
Nemes, Karolina
Johann, Pascal D.
Wissenschaftlicher Artikel
Published in
The American Journal of Surgical Pathology ; 46 (2022), 9. - S. 1277-1283. - ISSN 0147-5185. - eISSN 1532-0979
Link to publication
https://dx.doi.org/10.1097/PAS.0000000000001905Institutions
UKU. Institut für HumangenetikSubject headings
[Free subject headings]: atypical teratoid | rhabdoid tumor | TP53 | germline | SMARCB1 | INI1 | SMARCA4 | Brg1 | DNA methylation profiling | ATYPICAL TERATOID/RHABDOID TUMOR | CENTRAL-NERVOUS-SYSTEM | IMMUNOHISTOCHEMICAL ANALYSIS[DDC subject group]: DDC 610 / Medicine & health